Rice Partnership’s Pfizer PFE Stock Holding History

Rice Partnership’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,443	Closed	-$247K	–	131
2023 Q3	$247K	Sell	7,443 -6,536	-47%	-$231K	0.07%	89
2023 Q2	$513K	Sell	13,979 -124,899	-90%	-$4.86M	0.14%	68
2023 Q1	$5.67M	Buy	138,878 +2,499	+2%	+$108K	1.7%	17
2022 Q4	$6.99M	Buy	136,379 +8,232	+6%	+$395K	2.21%	15
2022 Q3	$5.61M	Buy	128,147 +26,897	+27%	+$1.31M	1.8%	18
2022 Q2	$5.31M	Buy	101,250 +4,075	+4%	+$208K	1.86%	18
2022 Q1	$5.03M	Buy	97,175 +48,188	+98%	+$2.5M	1.45%	24
2021 Q4	$2.89M	Buy	48,987 +5,684	+13%	+$282K	0.82%	33
2021 Q3	$1.86M	Buy	+43,303	New	+$1.92M	0.59%	37
2021 Q1	–	Sell	-23,325	Closed	-$859K	–	117
2020 Q4	$859K	Sell	23,325 -870	-4%	-$31.9K	0.32%	50
2020 Q3	$842K	Sell	24,195 -825	-3%	-$28.9K	0.37%	42
2020 Q2	$776K	Sell	25,020 -1,620	-6%	-$55K	0.4%	39
2020 Q1	$825K	Sell	26,640 -5,773	-18%	-$197K	0.55%	37
2019 Q4	$1.21M	Sell	32,413 -3,672	-10%	-$131K	0.66%	39
2019 Q3	$1.23M	Sell	36,085 -3,525	-9%	-$128K	0.77%	33
2019 Q2	$1.63M	Sell	39,610 -2,077	-5%	-$82.5K	1.1%	25
2019 Q1	$1.68M	Hold	41,687	–	–	1.22%	26
2018 Q4	$1.73M	Sell	41,687 -4,612	-10%	-$191K	1.55%	23
2018 Q3	$1.94M	Sell	46,299 -24,502	-35%	-$943K	1.22%	27
2018 Q2	$2.44M	Buy	70,801 +442	+0.6%	+$15.1K	1.6%	22
2018 Q1	$2.37M	Buy	70,359 +6	+0%	+$206	1.58%	20
2017 Q4	$2.42M	Buy	+70,353	New	+$2.4M	1.7%	20

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Rice Partnership's PFE Position: Q4 2023 in Review

Rice Partnership sold out of Pfizer (PFE) in Q4 2023, closing a stake of 7,443 shares — an estimated $247K sold.

Rice Partnership first reported a position in PFE in Q4 2017 and held it in 22 quarters. The position peaked at $6.99M in Q4 2022. 2,936 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

Rice Partnership reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
Rice Partnership sold 7,443 Pfizer shares in Q4 2023, an estimated $247K.
Rice Partnership first reported a position in Pfizer in Q4 2017 and held it in 22 quarters.
Rice Partnership's Pfizer position peaked at $6.99M in Q4 2022.
2,936 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Rice Partnership's 13F filing for Q4 2023, filed 12 Feb 2024.